JOSEPH L HERRING

CIK 1229873 · CEO of Covance Drug Division · last filed 2026-03-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.50M

Companies

4

Total Filings

56

Lifetime Open-Market Net

-$56.74M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HSIC Director 31,859 $81.25 $2.59M $127.1K 14 2026-03-09
TMH Director 2,982 $49.12 $146.5K $0 4 2016-05-24
LH CEO of Covance Drug Division 10,404 $266.16 $2.77M -$4.49M 3 2015-08-04
COVANCE INC (CVD) Delisted Chairman and CEO 175,643 -$52.38M 34 2014-12-19

Recent Filings · Page 6 of 6

56 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2008-09-12 COVANCE INC (CVD) Delisted Mixed -$3.89M EDGAR
2008-02-22 COVANCE INC (CVD) Delisted Mixed +27,569 -$133.7K EDGAR
2007-12-31 COVANCE INC (CVD) Delisted Sell (S) −40,000 -$3.49M EDGAR
2007-12-20 COVANCE INC (CVD) Delisted Tax (F) −19,552 -$1.70M EDGAR
2007-05-18 COVANCE INC (CVD) Delisted Mixed -$2.81M EDGAR
2007-02-23 COVANCE INC (CVD) Delisted Mixed +85,224 -$170.8K EDGAR
Showing 5156 of 56
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.